Jeff Carroll is part of a new effort to accelerate the development of targeted cures for a handful of neurodegenerative ...

The Allen Institute is launching a $200 million initiative, the Brain Health Accelerator, to develop gene therapies for ...

The Allen Institute, together with partner organizations, today launched the Brain Health accelerator: an ambitious global research initiative seeking to identify the specific brain cells and circuits ...

Scientists have launched an ambitious new effort to develop gene therapies for brain disorders, including Alzheimer's, Parkinson's, Huntington's and ALS.

Ketones have also been shown to reduce inflammation in mice models of Parkinson's and multiple sclerosis, boost an important ...

Researchers at the USC Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC have created one of the largest reference models ever developed ...

Dosing of adults with early Alzheimer’s disease in clinical trial expected H2 2026 -- Comprehensive preclinical program ...

Researchers are increasingly using AI to accelerate the search for treatments for neurological conditions such as Alzheimer’s ...

Manji is a professor at Oxford University, a professor (adjunct) at Yale University, and co-chair of the U.K. government Mental Health Goals program. Nestler is the Anne and Joel Ehrenkranz dean of ...

University of Oregon neuroscientists have identified a group of brain cells that essentially act as a "disappointment meter," ...

Kenneth Kendler, one of the most influential and prolific psychiatric researchers and historians of our time, recently published two articles examining the role of the brain in psychiatric disorders: ...

Menopause, the point around age 45-55 when menstruation permanently stops, is characterized by several physical and ...